INTERMITTENT PREVENTIVE TREATMENT USING ARTEMISININ-BASED COMBINATION THERAPY REDUCES MALARIA MORBIDITY AMONG SCHOOL-AGED CHILDREN IN MALI

被引:0
|
作者
Maiga, Hamma [1 ]
Barger, Breanna [2 ]
Traore, Oumar Bila [1 ]
Tekete, Mamadou [1 ]
Timbine, Antimbe [1 ]
Dara, Antoine [1 ]
Traore, Zoumana Isaac [1 ]
Gantt, Soren [3 ]
Doumbo, Ogobara [1 ]
Djimde, Abdoulaye [1 ]
机构
[1] MRTC DEAP, Bamako, Mali
[2] Univ Washington, Seattle, WA 98195 USA
[3] Seattle Childrens Hosp, Dept Pediat, Seattle, WA USA
来源
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
149
引用
收藏
页码:42 / 42
页数:1
相关论文
共 50 条
  • [21] Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria
    Muhindo, Mary K.
    Kakuru, Abel
    Jagannathan, Prasanna
    Talisuna, Ambrose
    Osilo, Emmanuel
    Orukan, Francis
    Arinaitwe, Emmanuel
    Tappero, Jordan W.
    Kaharuza, Frank
    Kamya, Moses R.
    Dorsey, Grant
    MALARIA JOURNAL, 2014, 13
  • [22] Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria
    Mary K Muhindo
    Abel Kakuru
    Prasanna Jagannathan
    Ambrose Talisuna
    Emmanuel Osilo
    Francis Orukan
    Emmanuel Arinaitwe
    Jordan W Tappero
    Frank Kaharuza
    Moses R Kamya
    Grant Dorsey
    Malaria Journal, 13
  • [23] An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malaria
    Pernaute-Lau, Leyre
    Camara, Mahamadou
    de Sousa, Tais Nobrega
    Morris, Ulrika
    Ferreira, Marcelo Urbano
    Gil, Jose Pedro
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2022, 18 (01) : 39 - 59
  • [24] Exploring the feasibility of introducing triple artemisinin-based combination therapy in the malaria treatment policy in Vietnam
    Van Anh Thi Cao
    Thieu Quang Nguyen
    Duong Le Quyen
    Wouter P. C. Boon
    Ellen H. M. Moors
    Arjen M. Dondorp
    Freek de Haan
    Chanaki Amaratunga
    Malaria Journal, 22
  • [25] Trends and predictive factors for treatment failure following artemisinin-based combination therapy among children with uncomplicated malaria in Ghana: 2005-2018
    Abuaku, Benjamin
    Duah-Quashie, Nancy Odurowah
    Quashie, Neils
    Gyasi, Akosua
    Afriyie, Patricia Opoku
    Owusu-Antwi, Felicia
    Ghansah, Anita
    Malm, Keziah Laurencia
    Bart-Plange, Constance
    Koram, Kwadwo Ansah
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [26] Exploring the feasibility of introducing triple artemisinin-based combination therapy in the malaria treatment policy in Vietnam
    Cao, Van Anh Thi
    Nguyen, Thieu Quang
    Le Quyen, Duong
    Boon, Wouter P. C.
    Moors, Ellen H. M.
    Dondorp, Arjen M.
    de Haan, Freek
    Amaratunga, Chanaki
    MALARIA JOURNAL, 2023, 22 (01)
  • [27] Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations
    Paulina Tindana
    Freek de Haan
    Chanaki Amaratunga
    Mehul Dhorda
    Rob W. van der Pluijm
    Arjen M. Dondorp
    Phaik Yeong Cheah
    Malaria Journal, 20
  • [28] ASSESSING THE IMPACT OF MALNUTRITION ON THE TREATMENT OUTCOME OF ARTEMISININ-BASED COMBINATION THERAPY IN UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA
    Stepniewska, Kasia
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 467 - 467
  • [29] Adherence to Artemisinin-Based Combination Therapy for the Treatment of Uncomplicated Malaria: A Systematic Review and Meta-Analysis
    Yakasai, Ahmad M.
    Hamza, Muhammad
    Dalhat, Mahmood M.
    Bello, Musa
    Gadanya, Muktar A.
    Yaqub, ZuwairaM.
    Ibrahim, Daiyabu A.
    Hassan-Hanga, Fatimah
    JOURNAL OF TROPICAL MEDICINE, 2015, 2015
  • [30] Pharmacokinetic Profile of Artemisinin Derivatives and Companion Drugs Used in Artemisinin-Based Combination Therapies for the Treatment of Plasmodium falciparum Malaria in Children
    Shane A. Pawluk
    Kyle J. Wilby
    Mary H. H. Ensom
    Clinical Pharmacokinetics, 2013, 52 : 153 - 167